{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:19:21Z","timestamp":1787761161102,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["CRC TRR152"],"award-info":[{"award-number":["CRC TRR152"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["567428938"],"award-info":[{"award-number":["567428938"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021711","name":"Bayerisches Staatsministerium fur Wissenschaft und Kunst","doi-asserted-by":"publisher","award":["15-25"],"award-info":[{"award-number":["15-25"]}],"id":[{"id":"10.13039\/501100021711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202440204"],"award-info":[{"award-number":["202440204"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bvth.2026.100187","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:10:14Z","timestamp":1784326214000},"page":"100187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New insights into flavonoid binding to the thromboxane A2 receptor"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-2196","authenticated-orcid":false,"given":"Chao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Lonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4276-4493","authenticated-orcid":false,"given":"Arthur","family":"Bassot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5481-6556","authenticated-orcid":false,"given":"Erika","family":"Cosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-0921","authenticated-orcid":false,"given":"Elmina","family":"Mammadova-Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-7965","authenticated-orcid":false,"given":"Thomas","family":"Gudermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8213-4728","authenticated-orcid":false,"given":"Attila","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bvth.2026.100187_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"37","key":"10.1016\/j.bvth.2026.100187_bib2","doi-asserted-by":"crossref","first-page":"26951","DOI":"10.1074\/jbc.M507469200","article-title":"Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein","volume":"281","author":"Khasawneh","year":"2006","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.bvth.2026.100187_bib3","doi-asserted-by":"crossref","first-page":"16791","DOI":"10.1074\/jbc.M105872200","article-title":"Mapping of a ligand-binding site for the human thromboxane A2 receptor protein","volume":"277","author":"Turek","year":"2002","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bvth.2026.100187_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbrc.2012.04.011","article-title":"A novel antibody targeting the ligand binding domain of the thromboxane A(2) receptor exhibits antithrombotic properties in vivo","volume":"421","author":"Murad","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.bvth.2026.100187_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bcp.2011.10.002","article-title":"The C-terminal segment of the second extracellular loop of the thromboxane A2 receptor plays an important role in platelet aggregation","volume":"83","author":"Murad","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.bvth.2026.100187_bib6","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.271.11.6233","article-title":"Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling","volume":"271","author":"D'Angelo","year":"1996","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bvth.2026.100187_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41589-018-0170-9","article-title":"Structural basis for ligand recognition of the human thromboxane A(2) receptor","volume":"15","author":"Fan","year":"2019","journal-title":"Nat Chem Biol"},{"issue":"14","key":"10.1016\/j.bvth.2026.100187_bib8","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1111\/j.1432-1033.2004.04232.x","article-title":"NMR structure of the thromboxane A2 receptor ligand recognition pocket","volume":"271","author":"Ruan","year":"2004","journal-title":"Eur J Biochem"},{"issue":"5","key":"10.1016\/j.bvth.2026.100187_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0026-895X(25)13289-6","article-title":"Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites","volume":"44","author":"Funk","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.bvth.2026.100187_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1074248411424145","article-title":"Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting","volume":"17","author":"Ting","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.bvth.2026.100187_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40265-017-0777-2","article-title":"Targeting the PGD(2)\/CRTH2\/DP1 signaling pathway in asthma and allergic disease: current status and future perspectives","volume":"77","author":"Kupczyk","year":"2017","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.bvth.2026.100187_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2125.2011.03985.x","article-title":"TP receptor antagonists (TXRAs): expensive irrelevance or wonder drugs strangled at birth?","volume":"71","author":"Ritter","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl 2","key":"10.1016\/j.bvth.2026.100187_bib13","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1097\/00005344-200606001-00014","article-title":"Dietary flavanols and platelet reactivity","volume":"47","author":"Holt","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.bvth.2026.100187_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2017.04.009","article-title":"Flavonoids and platelet aggregation: a brief review","volume":"807","author":"Faggio","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"1-2","key":"10.1016\/j.bvth.2026.100187_bib15","first-page":"76","article-title":"Antiplatelet effects of flavonoids mediated by inhibition of arachidonic acid based pathway","volume":"82","author":"Karlickova","year":"2016","journal-title":"Planta Med"},{"issue":"2","key":"10.1016\/j.bvth.2026.100187_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2125.2007.02881.x","article-title":"Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells","volume":"64","author":"Guerrero","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.bvth.2026.100187_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/092986707780090954","article-title":"SAR and QSAR of the antioxidant activity of flavonoids","volume":"14","author":"Amic","year":"2007","journal-title":"Curr Med Chem"},{"issue":"12","key":"10.1016\/j.bvth.2026.100187_bib18","article-title":"Flavonoids: potential therapeutic agents for cardiovascular disease","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bvth.2026.100187_bib19","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J Nutr Sci"},{"issue":"12","key":"10.1016\/j.bvth.2026.100187_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123106","article-title":"Synthetic flavonoids as novel modulators of platelet function and thrombosis","volume":"20","author":"Vallance","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bvth.2026.100187_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phymed.2017.08.023","article-title":"The isoflavonoid tectorigenin has better antiplatelet potential than acetylsalicylic acid","volume":"35","author":"Applova","year":"2017","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bvth.2026.100187_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1538-7836.2004.01099.x","article-title":"Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor","volume":"3","author":"Guerrero","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.bvth.2026.100187_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.thromres.2008.07.011","article-title":"Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets","volume":"123","author":"Munoz","year":"2009","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.bvth.2026.100187_bib24","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1021\/jf803041k","article-title":"Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships","volume":"57","author":"Navarro-Nunez","year":"2009","journal-title":"J Agric Food Chem"},{"issue":"13","key":"10.1016\/j.bvth.2026.100187_bib26","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.1074\/jbc.M209337200","article-title":"Identification of residues important for ligand binding of thromboxane A2 receptor in the second extracellular loop using the NMR experiment-guided mutagenesis approach","volume":"278","author":"So","year":"2003","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.bvth.2026.100187_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/jm00059a005","article-title":"Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction","volume":"36","author":"Yamamoto","year":"1993","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bvth.2026.100187_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(99)00007-1","article-title":"Possible role for ligand binding of histidine 81 in the second transmembrane domain of the rat prostaglandin F2alpha receptor","volume":"443","author":"Rehwald","year":"1999","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.bvth.2026.100187_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-69844-9","article-title":"Structural and dynamic insights into agonist recognition and function of the thromboxane A(2) receptor","volume":"17","author":"Krawinski","year":"2026","journal-title":"Nat Commun"},{"issue":"48","key":"10.1016\/j.bvth.2026.100187_bib30","doi-asserted-by":"crossref","first-page":"39716","DOI":"10.1074\/jbc.M507762200","article-title":"Aspirin induces platelet receptor shedding via ADAM17 (TACE)","volume":"280","author":"Aktas","year":"2005","journal-title":"J Biol Chem"},{"issue":"7637","key":"10.1016\/j.bvth.2026.100187_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \"resistance\" and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.bvth.2026.100187_bib32","first-page":"461","article-title":"The prevalence of aspirin resistance in patients with metabolic syndrome","volume":"37","author":"Cagirci","year":"2009","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"2","key":"10.1016\/j.bvth.2026.100187_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jth.12472","article-title":"Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation","volume":"12","author":"Capra","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"13","key":"10.1016\/j.bvth.2026.100187_bib34","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1111\/bph.12677","article-title":"Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation","volume":"171","author":"Bauer","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"5-6","key":"10.1016\/j.bvth.2026.100187_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1054\/plef.2002.0399","article-title":"Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets","volume":"66","author":"Csiszar","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"12","key":"10.1016\/j.bvth.2026.100187_bib36","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bcp.2008.03.014","article-title":"Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets","volume":"75","author":"Khasawneh","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"10.1016\/j.bvth.2026.100187_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28155904","article-title":"Tectorigenin: a review of its sources, pharmacology, toxicity, and pharmacokinetics","volume":"28","author":"Rong","year":"2023","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.bvth.2026.100187_bib38","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1021\/jp211904j","article-title":"Structure and elasticity of lipid membranes with genistein and daidzein bioflavinoids using X-ray scattering and MD simulations","volume":"116","author":"Raghunathan","year":"2012","journal-title":"J Phys Chem B"},{"issue":"1","key":"10.1016\/j.bvth.2026.100187_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1074\/jbc.M107832200","article-title":"Catalytic activity and chaperone function of human protein-disulfide isomerase are required for the efficient refolding of proinsulin","volume":"277","author":"Winter","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bvth.2026.100187_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0026-895X(25)11014-6","article-title":"Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses","volume":"39","author":"Nakashima","year":"1991","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100187_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0952-3278(93)90118-G","article-title":"The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase","volume":"48","author":"McNicol","year":"1993","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"16","key":"10.1016\/j.bvth.2026.100187_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26164911","article-title":"Soy isoflavones inhibit both GPIb-IX signaling and alphaIIbbeta3 outside-in signaling via 14-3-3zeta in platelet","volume":"26","author":"Liu","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bvth.2026.100187_bib43","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1021\/jf0723209","article-title":"Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway","volume":"56","author":"Navarro-Nunez","year":"2008","journal-title":"J Agric Food Chem"},{"issue":"5","key":"10.1016\/j.bvth.2026.100187_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/jcpt.12838","article-title":"Aspirin resistance mediated by oxidative stress-induced 8-isoprostaglandin F2","volume":"44","author":"Guo","year":"2019","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"10.1016\/j.bvth.2026.100187_bib45","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/ajcn\/76.5.1126","article-title":"Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women","volume":"76","author":"Bloedon","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.bvth.2026.100187_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ajcn\/75.1.126","article-title":"Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men","volume":"75","author":"Busby","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.bvth.2026.100187_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02850186","article-title":"Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers","volume":"22","author":"Ullmann","year":"2005","journal-title":"Adv Ther"},{"key":"10.1016\/j.bvth.2026.100187_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bcp.2016.11.010","article-title":"Impaired thromboxane receptor dimerization reduces signaling efficiency: a potential mechanism for reduced platelet function in vivo","volume":"124","author":"Capra","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100187_bib49","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1160\/TH13-08-0672","article-title":"A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction","volume":"111","author":"Nisar","year":"2014","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bvth.2026.100187_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/jth.12117","article-title":"Platelet dysfunction associated with the novel Trp29Cys thromboxane A(2) receptor variant","volume":"11","author":"Mumford","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bvth.2026.100187_bib51","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI117510","article-title":"Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder","volume":"94","author":"Hirata","year":"1994","journal-title":"J Clin Invest"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100187_bib52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1538-7836.2009.03399.x","article-title":"Human platelet pathology related to defects in the G-protein signaling cascade","volume":"7","author":"Van Geet","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bvth.2026.100187_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2009-08-236976","article-title":"A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis","volume":"115","author":"Mumford","year":"2010","journal-title":"Blood"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:25:15Z","timestamp":1787757915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2950327226000525"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100187","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into flavonoid binding to the thromboxane A2 receptor","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100187"}}